Dallas, TX -- (SBWire) -- 01/25/2011 -- GlobalData, the industry analysis specialist’s new report, “Irritable Bowel Syndrome – Drug Pipeline Analysis and Market Forecasts to 2016” is an essential source of information and analysis on the global irritable bowel syndrome market. The report identifies the key trends shaping and driving the global irritable bowel syndrome market. The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders. Most importantly, the report provides valuable insight on the pipeline products within the global irritable bowel syndrome sector.
This report is built using data and information sourced from proprietary databases, primary and secondary research and in house analysis by GlobalData’s team of industry experts.
Scope
The report provides information on the key driver and challenges of the global irritable bowel syndrome market. Its scope includes:
Annualized global irritable bowel syndrome market revenues data from 2000 to 2009, forecast for seven years to 2016.
Key geographies covered in this report include the US, the UK, Italy, Spain, Germany, France and Japan.
Pipeline analysis data providing a split across different phases, mechanisms of action being developed and emerging trends. The key classes of mechanism of action include guanylate cyclase type C receptor agonists, serotonin receptors targets, corticotrophin releasing factor 1 receptor antagonists, NK receptor targets and 5-aminosalicylate targets.
Analysis of the current and future market competition in the global irritable bowel syndrome market. Key market players covered include Sucampo Pharmaceuticals, Tillotts Pharma AG, GSK, Axcan Pharma, Salix Pharmaceuticals and Tioga Pharmaceuticals.
Insightful review of the key industry drivers, restraints and challenges. Each trend is independently researched to provide a qualitative analysis of its implications.
Key topics covered include a strategic competitor assessment, market characterization, unmet needs and implications for the future irritable bowel syndrome market.
Reasons to buy
The report will enhance your decision making capability in a more rapid and time sensitive manner. It will allow you to:
Develop and design your in-licensing and out-licensing strategies through review of pipeline products and technologies and by identifying companies with the most robust pipeline.
Develop business strategies by understanding the trends shaping and driving the global irritable bowel syndrome market.
Drive revenues by understanding key trends, innovative products and technologies, market segments and companies likely to impact the global irritable bowel syndrome market in future.
Formulate effective sales and marketing strategies by understanding the competitive landscape and by analyzing the performance of various competitors.
Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage.
Organize your sales and marketing efforts by identifying the market categories and segments that present maximum opportunities for consolidations, investments and strategic partnerships.
What’s the next big thing in the global irritable bowel syndrome market landscape? – Identify, understand and capitalize
Buy Now : Market Research
http://www.reportsnreports.com/
Related Reports
Irritable Bowel Syndrome – Pipeline Assessment and Market Forecasts to 2017
Acute Coronary Syndrome – Drug Pipeline Analysis and Market Forecasts to 2016
Polycystic Ovarian Syndrome – Drug Pipeline Analysis and Market Forecasts to 2016
Irritable Bowel Syndrome Therapy Area Pipeline Report
Digestive System Irritable Bowel Syndrome Therapy Area Pipeline Report
Irritable Bowel Syndrome – Pipeline Review, Q4 2010
Disease and Therapy Review: Irritable Bowel Syndrome
Irritable Bowel Syndrome Global Clinical Trials Review, Q4, 2010
Head and Neck Cancer – Drug Pipeline Analysis and Market Forecasts to 2016
Amyotrophic Lateral Sclerosis (Lou Gehrig’s) – Drug Pipeline Analysis and Market Forecasts to 2016
About ReportsnReports
ReportsnReports comprises of an online library of 50,000 reports, in-depth market research studies of over 5000 micro markets, and 25 industry specific websites. Our client list boasts of almost all well-known publishers of such reports across the globe. We, as a third party reseller of market research reports employ number of marketing tools such as press releases, email-marketing and effective search engine optimization technique to drive revenues for our clients.
Irritable Bowel Syndrome
The report also provides insight on the prevalent competitive landscape and the emerging players expected to bring significant shift in the market positioning of the existing market leaders.